Cargando…

Promising of Multidrug-resistant Tuberculosis Screening among New Tuberculosis Patients in China

Detalles Bibliográficos
Autores principales:	Zhang, Hui, Jia, Zhong-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586195/ https://www.ncbi.nlm.nih.gov/pubmed/28836569 http://dx.doi.org/10.4103/0366-6999.213433

Ejemplares similares

Multidrug-resistant tuberculosis in Sierra Leone
por: Lakoh, Sulaiman, et al.
Publicado: (2022)

Health-system reforms to control tuberculosis in China
por: Sleigh, Adrian C
Publicado: (2007)

Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
por: Li, Yang, et al.
Publicado: (2018)

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient
por: Helbling, P., et al.
Publicado: (2018)

A threat to decentralised care for drug-resistant tuberculosis
por: Gray, Adam T, et al.
Publicado: (2020)

Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013
por: Peng, Ying, et al.
Publicado: (2017)

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K, et al.
Publicado: (2021)

World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis
por: Ntoumi, Francine, et al.
Publicado: (2022)

Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China
por: Jia, Hongbing, et al.
Publicado: (2021)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K., et al.
Publicado: (2022)

Latent tuberculosis infection among contacts of patients with multidrug-resistant tuberculosis in New South Wales, Australia
por: Chang, Vicky, et al.
Publicado: (2021)

The incalculable costs of tuberculosis
por: Cox, Helen, et al.
Publicado: (2021)

Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients
por: Sharma, Surendra K., et al.
Publicado: (2011)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
por: Xia, Hui, et al.
Publicado: (2020)

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Multidrug-resistant tuberculosis transmission among middle school students in Zhejiang Province, China
por: Zhang, Yu, et al.
Publicado: (2020)

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
por: He, Guang Xue, et al.
Publicado: (2011)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
por: Kempker, Russell R., et al.
Publicado: (2015)

Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China
por: Zhang, Ming-Wu, et al.
Publicado: (2021)

Transmission of multidrug-resistant tuberculosis in Beijing, China: An epidemiological and genomic analysis
por: Yin, Jinfeng, et al.
Publicado: (2022)

Understanding spending trends for tuberculosis
por: Zwerling, Alice
Publicado: (2020)

Ferroptosis hijacking by Mycobacterium tuberculosis
por: Gan, Boyi
Publicado: (2023)

Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
por: Desissa, Fanta, et al.
Publicado: (2018)

Prevalence of Multidrug-Resistant Tuberculosis in Dalian, China: A Retrospective Study
por: Du, Liang, et al.
Publicado: (2021)

Transregional movement of multidrug-resistant tuberculosis in north China: an underlying threat to tuberculosis control
por: An, Jun, et al.
Publicado: (2016)

Accelerate investment and action to find the missing patients with tuberculosis
por: Dheda, Keertan, et al.
Publicado: (2022)

Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China
por: Zou, Jin, et al.
Publicado: (2022)

Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China
por: Lu, Zhenhui, et al.
Publicado: (2019)

Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
por: Lee, Hyun-Woo, et al.
Publicado: (2019)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Fistulized multidrug-resistant tuberculosis
por: El Omri, Naoual, et al.
Publicado: (2017)

Pharmacotherapy for multidrug resistant tuberculosis
por: Chhabra, Naveen, et al.
Publicado: (2012)

The Threat of Multidrug-resistant Tuberculosis
por: Paul, Rudrajit
Publicado: (2018)

The importance for tuberculosis of mitigating economic crises
por: Rasella, Davide, et al.
Publicado: (2022)

Tuberculosis control is crucial to achieve the MDGs
por: Atun, Rifat, et al.
Publicado: (2010)

Ending tuberculosis by 2030: understanding the transmission
por: Pandey, Basu Dev, et al.
Publicado: (2023)

Mediating Effect of Repeated Tuberculosis Exposure on the Risk of Transmission to Household Contacts of Multidrug-Resistant Tuberculosis Patients
por: Lu, Peng, et al.
Publicado: (2018)

Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India
por: Dierberg, Kerry L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nv0qh71rcqj6t5cgogumm5uf03